Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study
about
Effectiveness of Ivabradine in Treating Stable Angina PectorisAdvances in the management of heart failure: the role of ivabradineHeart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial InfarctionNonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Impact of Heart Rate on Myocardial Salvage in Timely Reperfused Patients with ST-Segment Elevation Myocardial Infarction: New Insights from Cardiovascular Magnetic Resonance.Is there a role for ivabradine beyond its conventional use?Ivabradine in Management of Heart Failure: a Critical Appraisal.Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.Pleiotropic, heart rate-independent cardioprotection by ivabradine.Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs.Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease.
P2860
Q26750710-A4C8906C-7DFB-4F45-AD46-6097CB1E236EQ28072418-2F7712A5-EF8C-4E4D-8BF1-9BE808AA9A15Q30276924-649F90D2-A9C2-4E6C-B85F-8316C7398B07Q30583012-0378B508-0762-41EB-8B11-10E8D1135E72Q35881505-02AE687B-7A78-46F7-AADE-BA3BFECAA3C4Q38211780-05BC211D-4396-45C1-8283-AADAB04A0ECBQ38546740-B4F6027D-4C5C-42BC-BA66-DBA810EC0E8FQ38797276-D37EE02F-79B1-447F-B822-D1B4166DC9D1Q38986970-14D8C9E9-312B-44A4-9C20-D35E8B2DDD5AQ42205768-A3F242E5-3B9C-4308-992D-0E69695CC198Q42871311-8B3FB49F-D592-437E-9B84-8328CAA10E7BQ48227365-496D96F2-3E73-4ACF-8778-A9791B592856Q51006365-B002C430-7B86-4BCC-AFEF-F073A6BB2822Q53796787-A132891C-177E-487D-9AB2-19F8F6FCFA55
P2860
Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of intravenous ivabradi ...... led, double-blind, pilot study
@en
Safety of intravenous ivabradi ...... ed, double-blind, pilot study.
@nl
type
label
Safety of intravenous ivabradi ...... led, double-blind, pilot study
@en
Safety of intravenous ivabradi ...... ed, double-blind, pilot study.
@nl
prefLabel
Safety of intravenous ivabradi ...... led, double-blind, pilot study
@en
Safety of intravenous ivabradi ...... ed, double-blind, pilot study.
@nl
P2093
P2860
P356
P1476
Safety of intravenous ivabradi ...... led, double-blind, pilot study
@en
P2093
E Lopez-de-Sà
J Goicolea
J L Lopez-Sendon
T Meinertz
VIVIFY (eValuation of the Intr ...... dial infarction) investigators
P2860
P304
P356
10.1177/2048872613489305
P577
2013-09-01T00:00:00Z